Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All
Sort by:
Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth

Published: Jan-2019

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female.....

$4995
More Info
Global Rheumatic Disorders Drugs Market to 2024 – Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

Published: Jan-2019

The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective.....

$4995
More Info
Global Dermatology Drugs Market to 2024 – IL Signaling Inhibitors to Overtake TNF-a Inhibitors as Leading Commercial Drug Class with Dupixent and Cosentyx among Key Performers

Published: Dec-2018

Dermatological conditions, diseases of the skin, hair and nails, are one of the most common types of disorders worldwide,.....

$4995
More Info
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 – Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market

Published: Dec-2018

Non-alcoholic steatohepatitis (NASH) is the severe form of non-alcoholic fatty liver disease (NAFLD), characterized by.....

$4995
More Info
Epilepsy Therapeutics in Asia-Pacific Markets to 2024 – Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth

Published: Nov-2018

Epilepsy is a chronic disorder of the brain with substantial morbidity. There are more than 65 million people with epilepsy.....

$4995
More Info
Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 – Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

Published: Nov-2018

Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex.....

$4995
More Info
Global Orphan and Rare Dermatology Drugs Market to 2024 – An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

Published: Sep-2018

Dermatology is a highly diverse therapy area, in terms of severity and clinical presentation, which deals with diseases.....

$4995
More Info
Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy

Published: Sep-2018

Heart failure (HF) is a life-threatening syndrome with substantial morbidity and mortality. There are more than 26 million.....

$4995
More Info
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Published: Jul-2018

Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis.....

$4995
More Info
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

Published: Jul-2018

Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against.....

$4995
More Info
Sort by: